Science crowdfunding project VitaDAO has launched Matrix Biosciences, seeded with $300,000 and future funding via IP-NFT fractionalization.
VitaDAO, a decentralized autonomous organization dedicated to funding and advancing early-stage longevity research, has launched its first biotech firm Matrix Biosciences.
An initial tranche of $300,000 from VitaDAO will be made available to Matrix Bio, followed by additional funding through IP-NFT fractionalization in early 2024 — non-fungible tokens intended to represent intellectual property. VitaDAO is part of a nascent movement known as decentralized science or DeSci. In contrast to the current system, which relies on centralized bodies for research and funding, DeSci aims to source research investment through crowdfunding initiatives and decentralized ownership.The funds will be used for preclinical studies testing novel hyaluronic acid-based compounds found in long-living cancer-resistant naked mole rats.
“Thanks to the collective drug development experience from VitaDAO’s online community and the collaborative nature and expertise of Dr. Gorbunova and the Matrix Biosciences team, we now have a well-designed development strategy in an area that has traditionally lacked the know-how or an established path,” VitaDAO company builder Dr. Anthony Schwartz added. “We are pleased with the early data generated thus far and its potential for advancing into clinical trials.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Graphene’s Twisted Science: A New Quantum Ruler To Explore Exotic MatterScience, Space and Technology News 2023
Baca lebih lajut »
Diagnosing the Problems With the Science of ConsciousnessThe science of consciousness is facing severe conceptual problems. A new unified theory of knowledge can help point the way toward better understanding.
Baca lebih lajut »
Science news this week: Norse treasures and Nobel PrizesAlexander McNamara is the Editor-in-Chief at Live Science, and has more than 15 years’ experience in publishing at digital titles. More than half of this time has been dedicated to bringing the wonders of science and technology to a wider audience through editor roles at New Scientist and BBC Science Focus, developing new podcasts, newsletters and ground-breaking features along the way. Prior to this, he covered a diverse spectrum of content, ranging from women’s lifestyle, travel, sport and pol
Baca lebih lajut »
This Science-Fiction Writer Thinks AI Needs Its Own BodyAnn Leckie, author of the award-winning novel ‘Ancillary Justice,’ on the future of AI: ‘I think there’s a mechanical answer’
Baca lebih lajut »
10 Great Books About AI for Your Science-Fiction Reading ListHere are some Journal staff favorites that envision myriad futures for artificial intelligence
Baca lebih lajut »
COVID Masking Hysteria Was Never About Following the Science | OpinionBy the spring of 2020, when I returned from my COVID sabbatical, all previous knowledge of immunity seemed to have been discarded.
Baca lebih lajut »